Loading...
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
During the past decades, candidate drugs that have shown neuroprotective efficacy in the preclinical setting have failed in clinical stroke trials. As a result, no treatment for stroke based on neuroprotection is available today. The activation of the glucagon-like peptide 1 receptor (GLP-1) for red...
Na minha lista:
| Udgivet i: | J Cereb Blood Flow Metab |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4420864/ https://ncbi.nlm.nih.gov/pubmed/25669907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.17 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|